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Abstract A systematic literature review was conducted
to summarize the existing evidence on presumed determi-
nants of heart failure (HF) medication adherence. The aim
was to assess the evidence and provide directions for future
medication adherence interventions for HF patients. Based
on a search in relevant databases and a quality assessment,
eleven articles were included in the review. A best evi-
dence synthesis was used to combine the results of pre-
sumed determinants that were found more than once in the
literature. Results were classified according the World
Health Organization’s (WHO) multidimensional adherence
model. Results demonstrated a relationship between having
been institutionalized in the past (including hospitaliza-
tions and nursing home visits) and higher adherence levels.
This finding is related to the healthcare system dimension
of the WHO model. The presumed determinants related
to the other dimensions, such as social and economic factors,
condition-related, therapy-related, and patient-related factors
of the multidimensional adherence model all had inconsistent
evidence. However, there was also an indication that patients’
educational level and the number of healthcare professionals
they have visited are not related to higher adherence levels.
Based on the current review, HF patients who have been
institutionalized in the past are more adherent to HF medi-
cation. Many other presumed determinants were investigated,
but displayed inconsistent evidence. Due to the lack of evi-
dence, it was not possible to make recommendations for
future interventions.
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Introduction
Heart failure (HF) is a chronic cardiac condition prevalent
especially among the elderly, characterized by high mor-
tality and hospitalization rates [1]. The European Society
of Cardiology [2], American College of Cardiology/
American Heart Association [3], and Heart Failure Society
of America [4] guidelines for HF treatment specify both
pharmacological and non-pharmacological treatment
strategies. The objectives of pharmacological treatment in
HF include reduction in mortality and morbidity and pre-
vention of further worsening of the condition [2].
Adherence to medication is defined as the extent to
which patients take medications they have been prescribed
[5]. Non-adherence to medication is pervasive among
patients of chronic diseases, although there is no standard
as to what constitutes adequate adherence [5]. A meta-
analysis of 569 studies on patient adherence to medication
reveals that the rate of non-adherence is on average 24.8 %
in the general patient population [6]. Among HF patients,
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the rates of adherence reported in studies vary between 10
and 98 %, depending on the measurement instruments used
[7]. Non-adherence to HF medications is related to poor
clinical outcomes and high healthcare costs [8].
Adherence to medication can be promoted through
various interventions. A recent study that measured
healthcare professionals’ strategies to promote medication
adherence showed that educational/cognitive interventions
were the most common, followed by counseling/behavioral
interventions [9]. In order to devise effective tailored and
targeted interventions, it is important to determine which
factors are associated with, and may reduce levels of, non-
adherence. The World Health Organization (WHO) defines
five dimensions of adherence [10]. These are social and
economic factors, healthcare system-related factors, con-
dition-related factors, therapy-related factors, and patient-
related factors.
A best evidence synthesis is a method of synthesizing
evidence used in literature reviews, in which the best
available evidence is utilized to produce and defend con-
clusions [11]. A possible conclusion to be reached as a
result of performing best evidence synthesis may be that
the available evidence does not allow reaching any con-
clusions. Performing this method of best evidence synthe-
sis includes assessing the internal and external validity of
studies and weighing the evidence based on the studies’
scientific rigor. Before performing the best evidence syn-
thesis, criteria for rating the levels of evidence should be
defined. These can be derived from previous literature [11].
In order to summarize the available evidence and reach
conclusions about the levels of evidence, we relied on the
principles of a best evidence synthesis.
The aim of the current systematic literature review is to
assess the level of evidence for presumed determinants of
medication adherence and make recommendations for
future interventions to increase adherence levels. This is
the first review to systematically assess the evidence for
determinants of HF medication adherence, using a meth-
odological quality assessment [12] and a best evidence
synthesis [11, 13, 14].
Method
The study selection process included four steps: a search in
the electronic databases, scanning of titles and abstracts to
select relevant articles, scanning the full text articles and
applying inclusion and exclusion criteria to select eligible
articles, and conducting a methodological quality assess-
ment to remove poor-quality studies.
Search of literature in electronic databases
The literature search was conducted in five electronic dat-
abases (Fig. 1) in August 2010. Limits were set on full text
but not on dates. The search included titles on HF behaviors
associated with both pharmacological (medication adher-
ence) and non-pharmacological (lifestyle) recommenda-
tions. The results on the HF self-care behaviors other than
medication adherence have been reported elsewhere [15].
Fig. 1 Flowchart of article
selection process
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Review of titles, abstracts, and full text articles
In the second step of the article selection process, two
authors (ROC and AJvB) independently scanned the titles
and abstracts generated by the search. The two authors then
made decisions about inclusion based on the relevance of
the articles to the topic of the review, compared their
decisions and reached consensus. If there was lack of
consensus, a third author was consulted (CBT).
Next, an inclusion and exclusion criteria list was
devised, so that it can be used to select eligible studies in
the next step of the study selection process. Studies were
selected if they met the following inclusion criteria (IC):
1. At least 50 % of the sample consisted of HF patients.
2. One or more presumed determinants of medication
adherence were investigated
3. Medication adherence was (one of the) main
outcomes.
4. Quantitative results were reported.
5. Published in English.
Studies were excluded if they met the following exclu-
sion criteria (EC):
1. Review papers.
2. Evaluations of interventions were their main purpose.
3. Descriptive studies.
In the third step of the article selection process, the two
authors scanned the full texts of the selected articles, and
selected articles for inclusion based on the criteria inde-
pendently and compared their selections. If there was lack
of consensus on methodological issues, a third author was
consulted (CBT). If there was disagreement about clinical
aspects, a fourth author was consulted (TJ).
Methodological quality assessment
A checklist that was devised (Table 1) based on the Quality
in Prognosis studies (QUIPS) tool, designed for systematic
reviews of prognostic studies through international expert
consensus [12]. The QUIPS tool contains six categories
assessing (1) bias due to patient selection, (2) attrition, (3)
measurement of prognostic factors, (4) outcome measure-
ment, (5) confounding on statistical analysis, and (6) con-
founding on presentation. To strengthen the discriminative
capacity of the checklist, the description of each category
was transformed into a set of individual questions that were
scored separately.
In the fourth step of the article selection process, the two
authors independently assessed the quality of each study
and compared their results. Specifically, a quality score of
between 1 and 3 was provided for all items on the quality
checklist (Table 1), for each study separately. If there was
lack of consensus, a third author was consulted (CBT).
After consensus was reached, an average quality score
(range 1–3) was computed for each study. Studies that
received an average quality score of between 2.5 and 3.0
were regarded as good-quality studies, those that received
an average score between 2.0 and 2.4 or less were regarded
as fair-quality studies, and those that received an average
score of below 2.0 were regarded as poor-quality studies.
In the current review, only studies of at least fair quality
(i.e., with an average quality score C2.0) are included in
the analysis. Since seven studies had an average quality
score lower than 2.0, eleven studies were included and
taken to the next step in the review process, and seven
studies were excluded (Table 2) [16–22].
Extraction of data
After the study selection process, data were extracted from
the selected articles. Two authors (ROC and AJvB) inde-
pendently extracted the study characteristics (author, year,
outcome variable(s), sample characteristics, presumed
determinants, measurement instruments, and significant
results (statistical figures that were reported in the article),
of studies selected for inclusion. Differences were dis-
cussed and consensus was reached. In case of disagree-
ment, a third author was contacted (CBT). Continuous
rather than categorical statistics were extracted from arti-
cles when both were reported.
Rating the levels of scientific evidence
To synthesize the results, the principles of best evidence
synthesis [11, 13, 14] were applied. Specifically, information
was incorporated on the number of studies, the methodo-
logical quality of the studies, and the consistency of the
results. This rating system is based on levels of evidence as
described by review groups from the Cochrane Collabora-
tion [12]. Results were considered consistent (Table 3) when
at least 75 % of the studies demonstrated results in the same
direction, according to statistical significance of p \ 0.05.
In the results section, only the results on presumed
determinants that were investigated in more than one of the
included studies are discussed, since, according to the best
evidence synthesis, only the evidence regarding determi-
nants which were investigated more than once can be syn-
thesized. However, the results that were found in single
studies are displayed in Table 4. The results section is
organized according to the WHO multidimensional adher-
ence model [10]. In addition, results are depicted in so called
Harvest plots [23] in order to provide a visual overview of the
number and quality of the studies that showed positive
relationships, negative relationships, or no relationships
between the determinants and medication adherence
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(Figs. 2–5). Moreover, these results are stratified by mea-
surement technique of the outcome variable.
Results
Studies selected
As previously described, a number of steps led to the final
selection of studies included in the review. The titles and
abstracts of 6683 articles were scanned and assessed for
relevance, leading to a selection of 87 articles (Fig. 1).
These articles’ full texts’ were scanned, and the inclusion
and exclusion criteria were applied. This step led to a
selection of eighteen studies eligible for inclusion, or
20.7 % of the 87 articles from the previous step. From the
69 excluded studies, 26 (37.1 %) had HF self-care behav-
iors other than medication adherence (including self-care
management, self-care maintenance, sodium, alcohol and
fluid intake restriction, physical activity, monitoring signs
and symptoms, and keeping follow-up appointments) as
their outcome, which were included in a previous review
[15], but excluded in the current review. These studies
were regarded as not meeting inclusion criterion (IC) 3,
described previously. Nineteen additional studies did not
meet IC 3, and therefore, 45 of 69 (65.2 %) studies in total
did not meet IC 3. The other 24 of the 69 excluded studies
were excluded for the following reasons: Four articles did
not meet IC 1, three did not meet IC 2, and five did not
meet IC 5. Moreover, two articles were excluded because
they met exclusion criterion (EC) 1, three met EC 2, and
seven met EC 3 (Fig. 1).
Table 1 Checklist of quality criteria used in the quality assessment
Methodological issue Questions addressed Scoring
Theoretical background 1. Is a theoretical background presented, to which the motivation for
conducting the study and/or the hypotheses are linked?
Y = 3, NR = 2, N = 1
Study participation 2. Is the study population clearly described in terms of age, gender,
and important HF characteristics?
Y = 3, NR = 2, N = 1
Y = 3, NR = 1, N = 2
3. Is the percentage of eligible subjects who participated in the study
(response rate) adequate?
Sampling 4. Are patients who participated in the study similar to eligible
non-participants, in terms of age, gender, and important disease
characteristics?
Y = 3, NR = 1, N = 2
Study attrition 5. Is the percentage of subjects available for analysis adequate
(i.e., [70 %)?
Y = 3, NR = 1, N = 2
Y = 3, NR = 1, N = 2
6. Were reasons for loss to follow-up presented and assessed during
the study for possible systematic attrition?
Determinant/correlate(s) measurement 7. Are clear definitions of each determinant and/or correlate provided? Y = 3, NR = 2, N = 1
Y = 3, NR = 2, N = 1
Y = 3, NR = 1, N = 2
Y = 3, NR = 2, N = 1
8. Are clear operationalizations of each determinant and/or correlate
provided?
9. Are the measurement instruments used for the measurement of the
determinants and correlates reliable and valid?
10. Were the measurement approach, time and place of measurement
of the determinants and/or correlates standardized or conducted in a
way that limits systematically different measurement?
Outcome variable(s) measurement 11. Are clear definitions of each outcome variable provided? Y = 3, NR = 2, N = 1
Y = 3, NR = 2, N = 112. Are clear operationalizations of each outcome variable provided?
13. Are the measurement instruments used for the measurement of the
outcome variable(s) reliable and valid?
Y = 3, NR = 2, N = 1
14. Were the measurement approach, time and place of measurement
of the outcome variable(s) standardized or conducted in a way that
limits systematically different measurement?
Y = 3, NR = 2, N = 1
Statistical analyses 15. Is the percentage of missing values adequate (i.e., \30 %)? Y = 3, NR = 1, N = 2
16. Were multivariable analyses performed? If yes, was it clearly
described which variables were included in the (multivariable)
model(s)?
Y = 3, NR = 1, N = 2
General question 17. Were there any other important flaws in the design or analyses
of the study?
Y = 3, NR = 2, N = 1
Y yes, N no, NR not reported
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Description and quality of the studies/data
The next step in the study selection process included an
assessment of the studies’ methodological quality. This
step led to an exclusion of seven of eighteen studies
(38.8 %), due to being having a poor methodological
quality according to the quality assessment. There were a
few pervasive methodological issues. Only one [22] of the
seven excluded studies (14.2 %) had a theoretical back-
ground. Only in one [18] of the excluded studies, the
number of reasons for loss to follow-up was reported. In
only one [21] of the excluded studies, the potential deter-
minants were defined, while for one of the excluded studies
this criterion was deemed irrelevant (16.6 %). Finally, in
only one [20] of the excluded studies, the number of
missing values in the data was reported.
On the other hand, in most [24–30] included studies
(seven of the nine studies for which this criterion was
deemed relevant, 77.7 %), the presumed determinants were
clearly defined. The outcome variable was operationalized
in all included studies. Multivariate analyses were per-
formed in all but one [26] of the included studies (90.9 %).
Six of eleven (55 %) included studies were rated good
quality [24–27] and five as fair-quality studies [30–33]
based on their average quality score (Table 2). The main
limitation of fair-quality studies were lack of theoretical
background and no reporting of missing values in the data
(Table 2).
Seven of the included studies were conducted in the US
[24, 25, 30–32], two were conducted in Australia [26], one
in the UK [27], and one included samples from 25 coun-
tries [33] (Table 4). All included studies reported on dif-
ferent samples (32 samples in total). Different methods
were used to measure adherence in the different studies,
including medication possession ratio (MPR), medication
event monitoring system (MEMS), interviews with
patients, and questionnaires (Table 4). All included studies
had demographic characteristics as presumed determinants,
and in most articles [24, 25, 29, 31–34], determinants
related to healthcare use, patients’ medical condition, and
Table 2 Quality assessment scores
Studies generated by search,





1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
1. Roe et al. [24] 3 3 3 I 3 2 3 3 3 3 3 3 3 3 1 3 3 2.8 Good
2. Bagchi et al. [25] 1 3 I I I I 3 3 I I 3 3 3 I 1 3 3 2.6 Good
3. Cholowski et al. [26] 3 3 3 I 3 2 3 3 I 3 3 3 2 3 3 2 3 2.6 Good
4. Molloy et al. [27] 3 3 3 3 2 2 3 3 3 3 1 3 3 3 1 3 3 2.6 Good
5. Sayers et al. [28] 1 3 3 3 2 1 3 3 3 2 3 3 3 2 3 3 3 2.6 Good
6. Schweitzer et al. [29] 1 3 1 1 3 I 3 3 3 3 3 3 3 3 3 3 3 2.6 Good
7. Wu et al. [30] 3 3 1 1 1 1 3 3 3 3 3 3 3 3 1 3 3 2.4 Fair
8. Evangelista et al. [34] 1 3 3 3 1 1 1 3 3 3 1 3 3 3 1 3 3 2.3 Fair
9. Monane et al. [31] 1 1 I I 1 1 I 3 3 I 3 3 1 3 1 3 3 2.1 Fair
10. Rodgers et al. [32] 1 3 I I 3 2 1 1 3 I 1 3 2 3 3 3 1 2.1 Fair
11. Granger et al. [33] 1 3 1 1 3 I I 2 2 2 1 3 2 2 1 3 3 2.0 Fair
12. Artinian et al. [22] 3 1 1 1 1 1 1 3 3 1 3 3 3 3 1 2 I 1.9 Poor
13. Evangelista et al. [16] 1 3 1 1 1 1 1 3 2 3 1 3 3 3 1 2 I 1.9 Poor
14. George and Shalansky [17] 1 3 2 2 1 1 1 1 I 3 1 3 3 3 1 3 1 1.9 Poor
15. Lamb et al. [18] 1 3 I I 1 3 1 1 2 2 1 3 3 2 1 3 1 1.9 Poor
16. Roe et al. [21] 1 1 I I 1 1 3 3 3 I 1 3 3 I 1 3 1 1.9 Poor
17. Pamboukian et al. [19] 1 3 I 1 1 1 I I 1 2 3 3 1 I 1 3 3 1.8 Poor
18. Ruf et al. [20] 1 3 1 1 2 1 1 1 1 3 3 3 2 3 2 2 1 1.8 Poor
Some criteria were deemed irrelevant for some studies. These cases appear in the table as ‘I’. Studies assessed as ‘poor’ had an average quality
score of less than 2 and were not included in the synthesis of the evidence
Table 3 Best quality synthesis applied on the extracted results
Level of evidence Consistent findings in multiple (C2) high-quality studies Strong evidence
Consistent findings in one high-quality study and at least
one fair-quality study or consistent findings in multiple fair-quality studies
Moderate evidence
Only one study available or inconsistent findings in multiple studies (C2) Inconsistent evidence





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Heart Fail Rev (2013) 18:409–427 419
123
aspects of the prescribed medication were investigated as
potential determinants.
Results of the best evidence synthesis
Social and economic factors
Age Eight of eleven included studies measured age as a
potential determinant of adherence to medication among
HF patients. However, these studies did not demonstrate
consistent results. Therefore, the evidence for the rela-
tionship was found to be inconsistent according to best
evidence synthesis. Specifically, four of the eight studies
that investigated age as a potential determinant [25, 31, 32,
34] showed a significant relationship between age and
adherence, while four did not find a significant relationship
between age and adherence [26, 29, 30, 33] (Fig. 2).
Of those that did find a significant relationship, three
studies [25, 31, 34] found that higher age is related to more
adherence. Another study [32] compared four age groups
(range 57–89) and found that age group 35–56 had the
highest level of adherence and age group 56–64 had the
lowest level of adherence (Fig. 2).
Sex Seven studies [24, 25, 29–33] investigated sex as a
potential determinant of medication adherence. Due to con-
flicting results, the evidence for the relationship was found
inconsistent according to best evidence synthesis. Although in
five studies (71 %) significant relationships between sex and
adherence were found, in three, it was demonstrated that men
were more adherent than women [24, 31, 33], while in two, it
was shown that men were less adherent than women [25, 31]
(Fig. 2). In another study, it was shown that men were more
likely to be non-adherent when they experienced feeling
physically bad as a result of taking medication [26]. However,
in the latter study, sex was not significantly related to non-
adherence to medication that has made one feel better or to
being careless about taking medications. Finally, in three
studies, no significant relationship between sex and adherence
was found [29, 30, 32] (Fig. 2).
Educational level The relationship between medication
adherence and educational level of HF patients [30, 34]
was investigated in two studies. In both of these studies,
educational level was not found to be related to medication
adherence. Since both of these studies were rated as fair-
quality studies (as indicated by the length of the bars in
Fig. 2), according to best evidence synthesis, there is
moderate evidence that patients’ educational level is not
related to their level of adherence.
Ethnicity Ethnic minorities were found to be less adher-
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five studies (60 %) that investigated this relationship, but in
two, no relationships were found [32, 34]. Therefore,
according to best evidence synthesis, the evidence for this
relationship is inconsistent due to insufficient evidence
(\75 %), indicating that the relationship exists. Specifi-
cally, two studies demonstrated that African Americans
were less adherent then Caucasians [25, 31]. One of them
also showed that people from ‘other’ races were more
adherent than African Americans and Hispanic people were
less likely to be adherent than Caucasians [30]. Among the
studies that did not find significant relationships, one dif-
ferentiated between African Americans and Caucasians
[32], and the other between African Americans, Cauca-
sians, and people of ‘other’ races [34]. As can be seen in
Fig. 2, pharmacy claims data were used to measure
adherence in the two studies that demonstrated that ethnic
majority group members are more adherent than minority
group members. However, in the study that did not dem-
onstrate this relationship, an electronic pill device was used
(Fig. 2).
Patient-related factors
Social support Two studies [28, 30] investigated whether
the level of social support that patients receive is related to
their level of medication adherence. Both articles used the
multidimensional Scale of Perceived Social Support to
measure social support, but only one study analyzed the
emotional and instrumental support subscales separately
[28]. In this study, a relationship was found between
medication adherence and emotional support but not
instrumental support. The degree of family members’ and
friends’ involvement in patients’ care was also measured in
this study, using the Medical Care Questionnaire. How-
ever, a relation to medication adherence was not found for
this measure of social support.
The other article [30] found that social support,
including emotional and instrumental support, was signif-
icantly related to adherence when it was calculated as the
amount of correct doses taken in a given day (dose day) but
not when it was calculated as the correct amount of doses
taken at the right time (dose time). As can be seen in Fig. 3,
both studies that found a relationship used pharmacy
claims data. The study that did not show a significant
relationship used an electronic pill count measure.
In sum, although significant positive relationships were
found between social support and medication adherence,
this was not the case when instrumental support was
measured independently or when the degree of family’ and
friends’ involvement was used as a measure of social
support. Therefore, the evidence for the relationship is
inconsistent according to best evidence synthesis,
Patient-perceived barriers to medication adherence The
barriers to medication adherence, as perceived by patients,
were measured with questionnaires in the three studies that
measured it as a potential determinant of medication
adherence. This relationship was found to be inconsistent
according to best evidence synthesis, because these studies
demonstrated conflicting evidence. Patients’ perceived
barriers were found to be related to adherence in two
studies [26, 30] (Fig. 3). In one [26], barriers to medication
adherence were negatively related to being careless about
taking medication. In this study, beliefs were measured
with an adapted version of the Compliance Beliefs Scale
[35]. Examples of items in this questionnaire include: ‘‘If I
take my water pills, I will lower my chance of being in the
hospital’’ and ‘‘Taking water pills is unpleasant.’’ In
another study [30], barriers to medication adherence were
related to less adherence, and this was measured with the
Medication Adherence Scale [36] that includes patient-
identified barriers such as ‘‘having no support from family
sisehtnysecnedivEpihsnoitalerehtfonoitceriD



























Each separate bar 
represents an article. The 
longer bars represent 
good quality articles and 
the short bars represent
moderate quality articles.
Fig. 2 Harvest plots displaying
the potential determinants found
more than once in the literature,
direction of the relationship
found, best evidence synthesis
results and techniques for
measuring adherence for socio-
economic factors
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or someone to remind me to take medications’’ or ‘‘con-
fusing the mediation times.’’ Finally, a third study did not
find significant relationships between beliefs and medica-
tion adherence [27]. This study used the Illness Perceptions
Questionnaire to measure beliefs [37]. In this study, a
cutoff p value of 0.10 was set, and the results are consid-
ered significant by the researchers.
Healthcare system-related factors
Healthcare services utilization Four included studies [24,
25, 31, 32] investigated whether various aspects of
healthcare services utilization were related to medication
adherence. These aspects include institutionalization (hos-
pitalization and nursing home stays), outpatient visits, and
number of healthcare professionals visited by patients. All
of these studies used pharmacy claims data to measure
adherence (Fig. 4).
Moderate evidence, according to best evidence synthe-
sis, was found for the relationship between institutionali-
zation and adherence. This relationship was investigated in
three studies [25, 31, 32], of which one was of good quality
and two were of fair quality, (Fig. 4). Although evidence
for the relationship was found in three studies, only one of
them is of good quality. This means that according to best
evidence synthesis, the evidence for this relationship is
moderate. The evidence from these studies indicates that
having been institutionalized in the past is related to higher
levels of adherence. In another study, a variable including
both hospitalization and nursing home stays was found to
be related to adherence [31]. Interestingly, it was also
found that hospitalization for other conditions than con-
gestive HF was related to a lower adherence level [25].
Another aspect of healthcare services utilization, which
was investigated in multiple included studies, was outpa-
tient visits. Best evidence synthesis showed that the rela-
tion between number of outpatient visits and medication
adherence in HF patients had inconsistent evidence. One
study [24] found a positive association between number of
outpatient visits and adherence, but another study [32] did
not find a relation between number of visits to the primary
care physician and adherence and between number of visits
to a pharmacist-managed outpatient clinics and adherence.
In addition, number of healthcare professionals seen is
yet another aspect of healthcare services utilization, which
was investigated in two included studies of moderate
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quality (Fig. 4). According to best evidence synthesis,
there was moderate evidence that seeing more healthcare
professionals is not related to more adherence [31, 32]. One
of the studies investigated this by measuring the number of
physicians seen [31], while the other measured the number
of healthcare professionals seen in general [32].
All of the studies that measured the relationship between
the various aspects of healthcare services utilization
described previously and medication adherence, used ret-
rospective claims data as a measure of medication adher-
ence (Fig. 4). These studies calculated medication
possession ratio, continuation of therapy, persistence, per-
centage acquisition of drugs, or prescription fillings (spe-
cific descriptions of how these were calculated in the
different studies can be seen in Table 4).
Condition-related factors
Comorbidities Four included studies investigated whe-
ther the number or type of HF comorbidities is related to
HF patients’ medication adherence. According to best
evidence synthesis, the evidence for the relationship
between number of comorbidities and adherence is incon-
sistent, due to conflicting results in the three studies that
investigated it. The number of comorbidites of HF patients
was significantly related to their adherence levels in two
studies [26, 33] that had opposite results (Fig. 5). Namely,
one study found that patients who felt worse after taking
medications and had more comorbidities were less likely to
stop taking medication [26]. Another study found that
having more comorbidities were related to less adherence
[33]. An additional study measured the relationship
between adherence and a risk score of comorbidity and
overall health status (using the Chronic Disease and
Disability Payment System scale) and found that patients
who had higher scores (more risk) had lower adherence
rates [25]. In addition, one study found a nonsignificant
relation between comorbidity and medication adherence
[30].
Three studies measured the relationship between having
a specific comorbidity and medication adherence. Having
the following comorbidities was related to higher adher-
ence levels: coronary artery disease, diabetes mellitus,
hyperlipidimemia and asthma/COPD [24, 25, 32]. Only
having renal insufficiency was found to be related to less
adherence and only when adherence was calculated as
medication possession ratio; when it was calculated by
measuring the continuation of therapy, it was related to
more adherence [24]. No relation was found between
having a prior myocardial infarction and medication
adherence [24]. It is not possible to synthesize the evi-
dence, because each of the aforementioned comorbidities
was investigated in a single study.
Functional status Functional status was measured with
the New York Heart Association (NYHA) class in the four
studies that investigated whether it is a potential determi-
nant of medication adherence. The evidence for the rela-
tionship, according to best evidence synthesis, was found
inconsistent because the evidence in the four studies that
investigated this relationship was conflicting. One study
demonstrated that patients with higher NYHA had lower
adherence [30] when calculating the percentage of days
that the correct doses were taken (Fig. 5). However, this
study did not find a significant relationship between NYHA
class and adherence when calculating adherence as the
percentage of doses taken or the percentage of doses taken
on schedule. Another study demonstrated that patients with
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higher NYHA had lower non-adherence [32], and three
studies [29, 30, 33] found a nonsignificant relationship
between these two variables.
Depression The evidence from the three studies that
investigated the relationship between depression and
medication adherence was inconsistent. Two studies [29,
30] demonstrated a nonsignificant relationship (Fig. 5). In
another study [26], it was found that depressed patients
were more likely than non-depressed patients to be careless
about taking medication but were not more likely than non-
depressed patients to stop taking medication when the
medication made them feel unwell, or when they were
feeling better. Depression was measured with question-
naires in these studies: the Patient Health Questionnaire in
one study [30] and with the Beck Depression inventory in
two others [26, 29]. In two of the three studies, adherence
was measured by self–report, while in the other study, it
was measured by an electronic pill device (see Fig. 5).
Treatment-related factors
Aspects of the prescribed medication Six of eleven
studies (54.5 %) measured potential determinants regard-
ing the prescribed medication (including being prescribed
various types of medications, having switched from one
type of medication to another, number of medications
prescribed, frequency of having to take medication, and
treatment-related barriers). Of these, in three studies [25,
31, 33], significant relationships were found between
aspects of the prescribed medication and adherence
(50 %); in two studies [24, 30], a significant relationship
was found with some aspects of the prescribed medication
but not with other aspects (33.3 %), and in one study [32],
a relationship was not found (16.6 %). The specific aspects
of the prescribed medication are displayed in the results
table (Table 4). It is not possible to synthesize the findings
of these results in order to draw conclusions, because each
of these studies measured different aspects of the pre-
scribed medication. However, since in five of eight studies
that investigated this relationship (62.5 %) some significant
relationships were found, there is an indication that aspects
related to the type of medication prescribed may be related
to adherence rates.
Discussion
The current review is the first to systematically assess the
evidence regarding presumed determinants of medication
adherence and to employ a quality assessment and a best
evidence synthesis. It is the most rigorous review on
determinants of medication adherence among HF patients
to date.
In the current review, eleven studies were included, six
of which were regarded as fair- and five as good-quality
studies. The reviewed articles reported on relationships
between medication adherence and a wide range of
potential determinants. However, most of the relationships
were rated inconsistent, usually because of conflicting
evidence for the relationships between the different deter-
minants. One relationship had moderate evidence, namely
the relationship between adherence and institutionalization.
In addition, there was moderate evidence that educational
level and seeing more healthcare professionals is not
related to medication adherence.
The results regarding institutionalization are difficult to
interpret. On the one hand, having had an institutionaliza-
tion (including hospitalization and nursing home stays) in
the past (the exact timeframe varied between the different
studies) was found to be related to higher levels of
adherence in the current review. On the other hand, the
relation between number of outpatient visits and adherence
was found to be inconsistent. Moreover, non-HF-related
hospitalizations were found to be unrelated to adherence in
one study [25]. There may be some differences between
these types of healthcare services that explain this result. It
could be that during hospitalization patients are informed
and even educated about the medications they should take,
that as the nurses pass by to give patients medications they
also stress the importance of taking medication and that
this does not occur during outpatient visits. It could also be
that more evidence is needed about the effects of outpatient
visits, which would change the picture. Finally, number of
healthcare professionals seen was found to be unrelated to
medication adherence, which means that seeing more
professionals does not improve adherence, but does not
harm it either.
Another possible explanation is that patients that have
worse health, and therefore have higher institutionalization
rates, are more motivated to adhere in order to reduce their
symptoms. However, the evidence for the relationship
between functional status and adherence was rated incon-
sistent in the current review due to conflicting evidence. It
could also be that patients’ perceptions of their health drive
motivation to adhere to treatment. It is possible that during
hospitalization patients develop a more negative view on
their health leading them to adhere to their medications
after discharge from the hospital.
Finally, it is possible that patients who have experi-
enced hospitalization become scared about being read-
mitted to the hospital. One study [38] gives an indication
for this interpretation. In this study, the adherence rates to
self-care recommendations of a group of patients receiv-
ing an educational in- and out-hospital intervention were
424 Heart Fail Rev (2013) 18:409–427
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compared with those of a control group receiving usual
care. The results showed that patients in both groups
increased their adherence levels after discharge, but that
patients who were in the intervention group sustained this
improvement for a period longer than 1 month. This
shows that recently discharged patients may be more
likely to adhere to recommendations. More research is
needed to establish why institutionalization benefits
adherence and which types of institutionalization benefit
it. Although institutionalization is not recommended as an
intervention to increase patients’ adherence, perhaps
providing adequate education to institutionalized patients
could increase adherence.
It is important to keep in mind that all the results
regarding healthcare services utilization in general, and
institutionalization in particular, come from pharmacy
claims data. These data demonstrate the rates at which
medications were claimed from pharmacies, but do not
demonstrate the rates at which medications were consumed
by patients. Therefore, these results should be interpreted
with caution. It remains to be seen whether patients that
were institutionalized in the past and are more likely to
claim medications are also more likely to consume the
medications they have claimed.
Although ethnicity had inconsistent evidence, this may
be due to the measurement techniques used to measure
adherence. In the two studies that found that ethnic
majority group members are more adherent than minority
group members, pharmacy claims data were used. In the
one study that did not find an association between ethnicity
and adherence, electronic pill counting device was used to
assess adherence. This means that it could be the case that
ethnic majority group members claim more medication
than ethnic minority group members, but they do not
consume more medication. In addition, the findings
regarding relationships between ethnic groups and medi-
cation adherence may be mediated by socio-economic
status. More research is warranted to clarify this topic.
Almost all studies that measured the relation between a
specific comorbidity and adherence found that patients who
had comorbidity were more adherent than those who did
not. However, studies that assessed the relation between
number of comorbidities and medication adherence paint
an inconsistent picture. It could be that it is not the number
of comorbidities that makes a difference, but rather the
type. Again, more research is needed in order to establish
the nature of the relationship.
It was apparent in the current review that aspects related
to the medication could be relevant determinants of
adherence. Perhaps different medications pose different
barriers to patients, because of different experienced side
effects. However, since each study included in the current
review measured a different aspect of the medication
prescribed, it is unclear which aspects are the important
ones. More research is warranted.
One of the aims of the current work is to provide rec-
ommendations for future interventions. This aim could not
be met due to the lack of consistent results on potential
modifiable determinants of medication adherence among
HF patients. It is suggested that future studies on HF
patients’ medication adherence investigate modifiable
determinants that have been found to affect levels of
adherence in other populations than HF. Important psy-
chological variables, such as self-efficacy, perceived ben-
efits and barriers and perceived risks of medication have
only been investigated in three of the included studies [26,
27, 29] but are constructs that could potentially be targeted
in interventions that aim to increase adherence to medi-
cation. More research is warranted on these as well as other
potential determinants that could be targeted in
interventions.
The current work reveals that few studies investigating
presumed determinants of medication adherence among
HF patients are available to date. The studies that are
available use a variety of methods to investigate both
presumed determinants and adherence levels, which
makes it difficult to compare the results. Although it has
been suggested that a diverse variety of variables affect
medication adherence of older adults [39], the studies
available to date on medication adherence among HF
patients demonstrate that many potentially important
determinants have only been investigated in a limited
number of studies at best. Some examples of possibly
important determinants include factors related to patients’
ability to acquire and retain information, such as cognitive
decline and health literacy. Variables such as patients’
living conditions and ability to purchase medication may
also be relevant. Such variables are not found in the
literature.
The evidence was conflicting and therefore regarded
inconsistent according to best evidence synthesis for most
potential determinants that were investigated more than
once. There are a few reasons for this. It could be that
different studies used different measurement instruments to
measure adherence, which may have led to variability in
the results. Another reason could be that different sub-
samples of HF were included in different studies, such as
patients of different age groups, different geographical
areas, and different levels of HF severity, and that for each
of these sub-groups different determinants are important.
The fact that there was a scarcity of studies of at least
fair quality limits the ability to draw far-reaching conclu-
sions and is a limitation of the current work. We reviewed
eleven studies and regarded only five of these as good-
quality studies. Notably, in the current review, seven of
eighteen studies were excluded from the analysis because
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they were regarded as poor-quality studies. The main
quality issues (as can be seen in Table 2) that these studies
had were related to lack of theoretical framework (all
excluded studies received the lowest possible score on this
quality item), not reporting whether the study had enough
participants available for analysis and not having provided
definitions of potential determinants and covariates (4 of 5
studies received the lowest possible score on these items).
It is especially important that future studies are of high
methodological quality.
Based on our results, it becomes apparent that there is no
clear profile for non-adherent HF patients, so it is not
possible to point to specific types of patients to whom
interventions to increase adherence should be directed.
However, it is apparent that institutionalization may benefit
HF medication adherence, possibly because having a
patient education program centered only on HF is benefi-
cial to adherence. Therefore, a possible intervention to
increase adherence rates may be education on HF medi-
cations during hospitalization. More research is needed on
other determinants of HF medication adherence to allow
making more recommendations for future interventions,
since most of the available evidence is conflicting.
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